Gsk (GLAXF) Shares Outstanding (Diluted Average) (2009 - 2018)
Gsk (GLAXF) recorded quarterly Shares Outstanding (Diluted Average) of $15.4 billion in Q1 2018, down 99.94% quarter-over-quarter from $26385.3 billion in Q1 2017, and down 99.94% on a YoY basis from $26385.3 billion in Q1 2017.
Gsk (GLAXF) Shares Outstanding (Diluted Average) (2009 - 2018) Analysis & Trends
Gsk's Shares Outstanding (Diluted Average) history runs 5 years deep, the most recent figure standing at $15.4 billion for Q1 2018.
- In Q1 2018, Shares Outstanding (Diluted Average) fell 99.94% year-over-year to $15.4 billion; the TTM figure through Mar 2018 stood at $15.4 billion (down 99.94% YoY), while the FY2010 annual figure was $51.0 billion, down 99.91% from the prior year.
- Shares Outstanding (Diluted Average) was $15.4 billion for Q1 2018 at Gsk, down from $26385.3 billion in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $26385.3 billion in Q1 2017 to a low of $15.4 billion in Q1 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,699,046.73 Bn | 93,699,041.77 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,012.06 Bn | 1,006.77 Bn | 16.22 Bn | 895.90 Mn |
| 3 | Johnson & Johnson | 560.67 Bn | 538.62 Bn | 15.96 Bn | 2.45 Bn |
| 4 | AbbVie | 402.20 Bn | 392.85 Bn | 10.78 Bn | 1.77 Bn |
| 5 | Merck | 298.59 Bn | 292.94 Bn | 12.09 Bn | - |
| 6 | Amgen | 188.77 Bn | 176.74 Bn | 5.87 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 160.22 Bn | 152.49 Bn | 5.52 Bn | 1.25 Bn |
| 8 | Pfizer | 148.19 Bn | 135.42 Bn | -1.21 Bn | 5.73 Bn |
| 9 | Bristol Myers Squibb | 116.72 Bn | 106.26 Bn | 8.07 Bn | - |
| 10 | Gsk | - | - | 7.76 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 15.44 Bn |
| Mar 31, 2017 | 26,385.32 Bn |
| Sep 30, 2011 | 43,802.79 Bn |
| Jun 30, 2011 | 40.27 Bn |
| Mar 31, 2011 | 51.08 Bn |
| Dec 31, 2010 | 52.14 Bn |
| Sep 30, 2010 | 70,237.55 Bn |
| Jun 30, 2010 | 3.73 Bn |
| Mar 31, 2010 | 47.45 Bn |
| Dec 31, 2009 | 57,335.07 Bn |
| Sep 30, 2009 | 46.43 Bn |
| Mar 31, 2009 | 37.65 Bn |